Effect of Nordic Walking Training Compared With Conventional Endurance Training in Walking Capacity in People With Multiple Sclerosis: a Simple Blinded Randomized Controlled Trial

CompletedNot a drug-phase studyMS (type not specified)NCT03976128

What it found

Paper found, not read

A paper reports the results; we have not read it yet. See Papers below.

What was tested

Treatment tested

  • Nordic Walking Training

Compared with

  • Conventional endurance training

What it measured

Main measures

  • 6 Minute Walk Test (6MWT)

    Assessment will take place at baseline and after 10 weeks

    Walking and mobility
  • Change from baseline 6 Minute Walk Test (6MWT) to 6 months

    Assessment will take place up to 6 months, through the study completion

    Walking and mobility

Other measures (14)

  • Timed 25 Foot Walk Test

    Assessment will take place at baseline and after 10 weeks

    Disability progressionWalking and mobility
  • Change from baseline Timed 25 Foot Walk Test to 6 months

    Assessment will take place up to 6 months, through the study completion

    Disability progressionWalking and mobility
  • Multiple Sclerosis Walking Scale 12

    Assessment will take place at baseline and after 10 weeks

    Walking and mobility
  • Change from baseline Multiple Sclerosis Walking Scale 12 to 6 months

    Assessment will take place up to 6 months, through the study completion

    Walking and mobility
  • Timed Up and Go Test

    Assessment will take place at baseline and after 10 weeks

    Walking and mobility
  • Change from baseline Timed Up and Go Test to 6 months

    Assessment will take place up to 6 months, through the study completion

    Walking and mobility
  • Berg Balance Scale

    Assessment will take place at baseline and after 10 weeks

    Walking and mobility
  • Change from baseline Berg Balance Scale to 6 months

    Assessment will take place up to 6 months, through the study completion

    Walking and mobility
  • Activities Specific Balance Confidence Scale

    Assessment will take place at baseline and after 10 weeks

    Walking and mobility
  • Change from baseline Activities Specific Balance Confidence Scale to 6 months

    Assessment will take place up to 6 months, through the study completion

    Walking and mobility

Who could take part

MS (type not specified) · 18 and over

Show the full criteria

Inclusion criteria

* People over 18 diagnosed of MS following the Mc Donald criteria, clinically stable who: * show mild to moderate balance disorder (BBS>45). Mild risk of falls. * refer fatigue during walking and restriction on their usual walking distance during the last 6 months. * Accept to participate in the study and signed the informed consent.

Exclusion criteria

* Other neurological disorders. * Moderate to severe spasticity (Ashworth>2) * Non stable heart diseases, diabetes mellitus, arthritis in lower limbs, acute pain in lower limbs, peripheral neuropathies, severe orthopedics problems, psychiatric problems, pregnancy. * Incapacity to maintain a minimum walking rhythm at least during 15 minutes. * Cognitive disability or body schema disorder that limits to fill in the assessment questionaires or understanding and applying the technique. * To be training in other physical activities that can modify the level of fatigue or walking ability.

As registered. Criteria can change, so ask the trial team or your neurologist.

About this trial

In the sponsor's words

Walking capacity is one of the most valuable body functions among persons with multiple sclerosis (MS) and it is one of the most frequently affected, even in early stages of the disease. Inactivity and deconditioning can accelerate gait impairment and promote other pathologies related with sedentary lifestyle. Nordic walking (NW) is a fun and effective fitness and rehabilitation activity. The benefits of NW have been extensively described in healthy and elderly population (Tschentscher, 2013; Kappor, 2013) and it is proving to be highly recommended to different neurological conditions, specially to Parkinson Disease (Reuter 2006; van Eijkeren 2008; Fritz 2011; Ebersbach 2014). There is no evidence on NW and MS, although it's supposed to be an ideal physical activity for many reasons: it tones the upper and lower body at the same time, uses 90% of the skeletal muscles, burns up to 46% more calories than ordinary walking, reduces the pressure on knees and joints, poles propel the walker along easier and faster and it is one of the most effective cross training techniques for people who require improve cardiovascular and endurance conditioning.

Papers

Loading reviews and guidelines…

History

    1. Started

      Sept 2016

    2. Main results due

      Jun 2019

    3. Finished

      Mar 2020

    Assembled by software from public sources.